Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant.
Hepatol Int
; 11(5): 434-439, 2017 Sep.
Article
in En
| MEDLINE
| ID: mdl-28083718
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Uridine Monophosphate
/
Benzimidazoles
/
Liver Transplantation
/
Hepatitis C, Chronic
/
Fluorenes
Type of study:
Guideline
/
Observational_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Hepatol Int
Year:
2017
Document type:
Article
Affiliation country:
United States
Country of publication:
United States